The Global Commercial Director will be a key member of the Global Calquence Astra Zeneca Team, accountable for shaping and delivering the global commercial strategy in Chronic Lymphocytic Leukemia (CLL).
Base: 231,989 to 347,983; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligibility; Benefits: Qualified retirement program, paid vacation and holidays, paid leaves, health benefits including medical, prescription drug, dental, and vision coverage
Must-have
Nice-to-have
Not specified